Related Experiment Video
Updated: Jun 9, 2025

Systematic Approach to Identify Novel Antimicrobial and Antibiofilm Molecules from Plants' Extracts and Fractions to Prevent Dental Caries
Published on: March 31, 2021
Novel Tricyclic Flavonoids as Promising Anti-MRSA Agents
Cristina-Veronica Moldovan1, Loredana-Elena Mantea1, Mihaela Savu1
1Department of Biology, Faculty of Biology, Alexandru Ioan Cuza University of Iasi, Bd. Carol I, No. 11, 700506 Iasi, Romania.
New tricyclic flavonoids show potent activity against Methicillin-resistant Staphylococcus aureus (MRSA). Compound 5e effectively inhibits and kills MRSA, offering a promising new agent for combating drug-resistant infections.
Area of Science:
- Medicinal Chemistry
- Microbiology
- Drug Discovery
Background:
- Methicillin-resistant Staphylococcus aureus (MRSA) poses a significant global health threat due to widespread antimicrobial resistance.
- MRSA infections are challenging to treat, leading to high mortality and substantial socioeconomic burdens.
- Developing novel anti-MRSA agents is a critical medical priority.
Purpose of the Study:
- To synthesize and evaluate a novel series of tricyclic flavonoids with a methyl substituent on ring A for antimicrobial properties.
- To assess the potential of these compounds as new therapeutic agents against drug-resistant bacteria, particularly MRSA.
Main Methods:
- Synthesis of novel tricyclic flavonoids and their 3-dithiocarbamic flavanone derivatives.
- Structural elucidation using X-ray crystallography.
- Antimicrobial activity assessment via Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal/Fungicidal Concentration (MBC/MFC) assays.
- Evaluation of antibacterial effectiveness using growth kinetic and time-kill assays.
- Investigation of the mechanism of action using fluorescence microscopy.
Main Results:
- The synthesized tricyclic flavonoids demonstrated significant antibacterial and antifungal activities.
- Compound 5e exhibited potent activity against a multidrug-resistant MRSA strain, with MIC and MBC values as low as 1.95 µg/mL and 3.90 µg/mL, respectively.
- Flavonoid 5e displayed notable bacteriostatic and bactericidal effects, outperforming chloramphenicol in inhibiting MRSA growth and causing cell death.
- The anti-MRSA mechanism is attributed to cell membrane impairment induced by compound 5e.
Conclusions:
- Flavonoid 5e emerges as a promising candidate for the development of novel anti-MRSA agents.
- Further research is warranted to fully explore the therapeutic potential of flavonoid 5e.
- The study highlights the potential of tricyclic flavonoids in addressing the challenge of antimicrobial resistance.
Related Concept Videos
Gene Regulation in Microbial Communities: Quorum Sensing
Surface Membrane Barriers
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
Combined Effects of Drugs: Synergism
Such synergistic combinations...

